Houston Rheumatology Institute PLLC

Houston Rheumatology Institute PLLC was paid $160K by Medicaid between Jan 2018 and Jul 2022, across 21 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 92% of everything it billed.

Compared with peers

Next to other Rheumatology Physician providers in Texas

Rank by total paid#7 of 45

Median peer was paid$12K

This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,376	$39K
2019	1,822	$113K
2020	478	$896.63
2021	205	$8K
2022	27	$158.58

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	92%	206	181	$148K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	4.4%	13	12	$7K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.8%	445	414	$4K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	288	256	$451.47
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	780	640	$133.47
G8482	Influenza immunization administered or previously received	0%	73	69	$0.00
96401		0%	13	12	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	249	232	$0.00
G8539	Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment	0%	45	41	$0.00
G8783	Normal blood pressure reading documented, follow-up not required	0%	85	79	$0.00
G8730	Pain assessment documented as positive using a standardized tool and a follow-up plan is documented	0%	176	161	$0.00
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	0%	83	77	$0.00

9 more codes

A4223	Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)	0%	58	$0.00
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	0%	138	$0.00
G9744	Patient not eligible due to active diagnosis of hypertension	0%	12	$0.00
1036F		0%	319	$0.00
G8510	Screening for depression is documented as negative, a follow-up plan is not required	0%	342	$0.00
1111F		0%	390	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	88	$0.00
G8430	Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status)	0%	13	$0.00
36000		0%	92	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKHAN, AMBER (PRESIDENT/OWNER)